Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Inhalation Anesthesia Market Research Report Information by Product (Sevoflurane, Isoflurane, Desflurane), Application (Induction, Maintenance) and Region - Global Forecast till 2032


ID: MRFR/HC/6587-HCR | 90 Pages | Author: Kinjoll Dey| April 2024
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Inhalation Anesthesia Market, by Product

6.1 Introduction

6.2 Sevoflurane

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Isoflurane

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Desflurane

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Inhalation Anesthesia Market, by Application

7.1 Introduction

7.2 Induction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Maintenance

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Inhalation Anesthesia Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Halocarbon Products Corporation

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Baxter

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Hikima Pharmaceuticals plc.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Lunan Pharmaceutical Group Co. Ltd

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Piramal Enterprises Limited

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Jiangsu Hengrui Medicine Co. Ltd

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Fresenius Kabi AG

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 AbbVie Inc.

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Other

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the global inhalation anesthesia market

Chapter 12 Appendix

LIST OF TABLES

Table 1 Inhalation Anesthesia Market Synopsis, 2020-2027

Table 2 Inhalation Anesthesia Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Inhalation Anesthesia Market, by Region, 2020-2027(USD Million)

Table 4 Global Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 6 Global Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 7 North America: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 9 North America: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 10 US: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 12 US: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 13 Canada: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 15 Canada: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 16 South America: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 18 South America: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 19 Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 21 Europe: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 22 Western Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 24 Western Europe: Inhalation Anesthesia Market, by Application, 2020-2027(USD Million)

Table 25 Eastern Europe: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 27 Eastern Europe: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 28 Asia-Pacific: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 30 Asia-Pacific: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

Table 31 Middle East & Africa: Inhalation Anesthesia Market, by Product, 2020-2027(USD Million)

Table 33 Middle East & Africa: Inhalation Anesthesia Market, Application, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Inhalation Anesthesia Market

Figure 3 Market Dynamics for Global Inhalation Anesthesia Market

Figure 4 Inhalation Anesthesia Market Share, by Product, 2020

Figure 6 Inhalation Anesthesia Market Share, Application, 2020

Figure 7 Inhalation Anesthesia Market Share, by Region, 2020

Figure 8 North America: Inhalation Anesthesia Market Share, by Country, 2020

Figure 9 Europe: Inhalation Anesthesia Market Share, by Country, 2020

Figure 10 Asia-Pacific: Inhalation Anesthesia Market Share, by Country, 2020

Figure 11 Middle East & Africa: Inhalation Anesthesia Market Share, by Region, 2020

Figure 12 Inhalation Anesthesia Market: Company Share Analysis, 2020 (%)

Figure 13 Halocarbon Products Corporation: Key Financials

Figure 14 Halocarbon Products Corporation: Segmental Revenue

Figure 15 Halocarbon Products Corporation: Geographical Revenue

Figure 16 Baxter: Key Financials

Figure 17 Baxter: Segmental Revenue

Figure 18 Baxter: Geographical Revenue

Figure 19 Hikima Pharmaceuticals plc.: Key Financials

Figure 20 Hikima Pharmaceuticals plc.: Segmental Revenue

Figure 21 Hikima Pharmaceuticals plc.: Geographical Revenue

Figure 22 Piramal Enterprises Limited.: Key Financials

Figure 23 Piramal Enterprises Limited: Segmental Revenue

Figure 24 Piramal Enterprises Limited: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.